A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA

被引：0

作者：

Grainger, J. ^{[1
]}

Bussel, J. ^{[2
]}

Cooper, N. ^{[3
]}

Tarantino, M. ^{[4
]}

Blanchette, V. ^{[5
]}

Despotovic, J. ^{[6
]}

Maschan, A. ^{[7
]}

Carpenter, N. ^{[8
]}

Eisen, M. ^{[9
]}

Mehta, B. ^{[9
]}

机构：

[1] Univ Manchester, Manchester, Lancs, England

[2] Weill Cornell Med, New York, NY USA

[3] Imperial Coll, Hammersmith Hosp, London, England

[4] Bleeding & Clotting Disorders Inst, Peoria, IL USA

[5] Hosp Sick Children, Toronto, ON, Canada

[6] Texas Childrens Hematol Ctr, Houston, TX USA

[7] Fed Res Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia

[8] Amgen Ltd, Uxbridge, Middx, England

[9] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P367

引用

页码：124 / 125

页数：2

共 50 条

[31] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Chen, Yuxi
Pan, Yuan
Xie, Yanyan
Shi, Yuxun
Lu, Yao
Xia, Yiwen
Su, Wenru
Chen, Xiaoqing
Li, Zuoyi
Wang, Minzhen
Miao, Siyu
Yang, Yating
Jin, Chenjin
Luo, Guangwei
Long, Shixian
Xiao, Hui
Huang, Chuangxin
Zhang, Jian
Liang, Dan
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
[32] EMBARK: A Phase 3b, Open-Label, Single-Arm, Safety Study to Evaluate the Long-Term Safety and Efficacy of Aducanumab in Eligible Participants With Alzheimer's Disease
Castrillo-Viguera, Carmen
Chalkias, Spyros
Burkett, Patrick
Wu, Shuang
Chen, Huaihou
Harrison, Katie
Yurgalevitch, Carol
Haeberlein, Samantha Budd
NEUROLOGY, 2021, 96 (15)
[33] Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
Ramanan, Ezhil Arasan
Ravi, Sailatha
Anbu, K. R. Radha
Michael, Margaret
DERMATOLOGY RESEARCH AND PRACTICE, 2020, 2020
[34] Update of An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)
Fenaux, Pierre
Kantarjian, Hagop M.
Muus, Petra
Lyons, Roger M.
Larson, Richard A.
Sekeres, Mikkael A.
Becker, Pamela S.
Jia, Catherine
Yang, Allen S.
BLOOD, 2011, 118 (21) : 1193 - 1194
[35] Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study
McDonnell, David P.
Landry, John
Detke, Holland C.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (06) : 322 - 331
[36] An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients (Pts) with Myelodysplastic Syndromes (MDS).
Fenaux, Pierre
Kantarjian, Hagop
Lyons, Roger
Larson, Richard A.
Sekeres, Mikkael A.
Becker, Pamela S.
Muus, Petra
Hu, Kuolong
Berger, Dietmar
Franklin, Janet L.
BLOOD, 2009, 114 (22) : 1081 - 1081
[37] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
Leonardi, Craig
Strober, Bruce
Gottlieb, Alice B.
Elewski, Boni E.
Ortonne, Jean-Paul
van de Kerkhof, Peter
Chiou, Chiun-Fang
Dunn, Meleana
Jahreis, Angelika
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
[38] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
Wroe, S
Brodie, MJ
EPILEPSIA, 2005, 46 : 118 - 118
[39] Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Chang, Xuting
Zhang, Jie
Jiang, Yuwu
Yao, Bufan
Wang, Jingmin
Wu, Ye
ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
[40] Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Xuting Chang
Jie Zhang
Yuwu Jiang
Bufan Yao
Jingmin Wang
Ye Wu
Orphanet Journal of Rare Diseases, 15

← 1 2 3 4 5 →